In the last trading session, 1.06 million shares of the Mereo Biopharma Group Plc ADR (NASDAQ:MREO) were traded, and its beta was 0.85. Most recently the company’s share price was $2.79, and it changed around $0.15 or 5.68% from the last close, which brings the market valuation of the company to $390.77M. MREO currently trades at a discount to its 52-week high of $4.36, offering almost -56.27% off that amount. The share price’s 52-week low was $0.92, which indicates that the current value has risen by an impressive 67.03% since then. We note from Mereo Biopharma Group Plc ADR’s average daily trading volume that its 3-month average coming to 1.56 million.

Mereo Biopharma Group Plc ADR (NASDAQ:MREO) trade information

Instantly MREO has showed a green trend with a performance of 5.68% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 20.78% year-to-date, but still up 4.49% over the last five days. On the other hand, Mereo Biopharma Group Plc ADR (NASDAQ:MREO) is -5.74% down in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $5, which translates to bulls needing to increase their stock price by 44.2% from its current value. Analyst projections state that MREO is forecast to be at a low of $4 and a high of $6.

Mereo Biopharma Group Plc ADR (MREO) estimates and forecasts

Mereo Biopharma Group Plc ADR share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 55.00 percent over the past six months and at a 115.00% annual growth rate that is well above the industry average of 13.30%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 41.78%.

MREO Dividends

Mereo Biopharma Group Plc ADR’s next quarterly earnings report is expected to be released around March 29 and April 02.